Open AccessViral infection parameters not nucleoside analogue itself correlates with host immunity in nucleoside analogue therapy for chronic hepatitis B
Author(s) -
Chengzhong Li,
Jingjing Hu,
Jianya Xue,
Wei Yin,
Yayun Liu,
Wenhan Fan,
Hao Xu,
Xuesong Liang
Publication year - 2014
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v20.i28.9486
Subject(s) - telbivudine , lamivudine , hbeag , medicine , immunology , cd8 , hepatitis b virus , nucleoside analogue , hepatitis b , cellular immunity , gastroenterology , virology , hbsag , immune system , virus , nucleoside , biology , biochemistry
To determine the relationship between host immunity and the characteristics of viral infection or nucleoside analogues (NAs) themselves in patients with chronic hepatitis B (CHB) receiving NA therapy.